SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 01, 17:00
859.90
0
VOLUME 308,222
LIVE
NSE
Apr 01, 17:00
859.80
0
VOLUME 5,415,702
News on Ranbaxy Laboratories
Select Year: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Like Sun Pharma, Strides Arcolab: Deepak Shenoy 

4.36 pm | 25 Aug 2015 |  Source: CNBC-TV18

Deepak Shenoy, Founder of Capitalmind.in likes Sun Pharma and Strides Arcolab and feels that pharma as a space is worth looking into....

Rupee fall to help pharma cos; top pick Lupin : JM Fin 

3.37 pm | 20 Aug 2015 |  Source: CNBC-TV18

Anmol Ganjoo of JM Financial says Lupin remains his top pick on perfect execution track records. He also says, sectoral tailwinds will help Sun Pharma...

Sun Pharma up 5%; BoAML upgrades to buy, weak rupee to aid

2.05 pm | 19 Aug 2015 |  Source: Moneycontrol.com

BoAML is betting big on Indian pharma companies as weak rupee is positive for the sector. It says Cadila, Aurobindo and Lupin are the biggest benefici...

Sun Pharma Q1 profit tanks 46% on Ranbaxy integration cost 

5.16 pm | 11 Aug 2015 |  Source: Moneycontrol.com

Revenue met expectations, growing 10 percent to Rs 6,767.6 crore in June quarter compared to Rs 6,157 crore in March quarter....

Pharma's open offer for Zenotech stake gets tepid response

9.50 pm | 24 Jul 2015 |  Source: PTI

Drug major Sun Pharmaceutical's open offer to acquire 28.16 percent stake in Zenotech Laboratories elicited tepid response from the shareholders. ...

What took mighty Lupin down! 

3.46 pm | 24 Jul 2015 |  Source: CNBC-TV18

In an interview with CNBC-TV18’s Sonia Shenoy & Latha Venkatesh, Praful Bohra, VP- Research, Religare said that Lupin’s numbers are weak due to de...

Wait 2-3 qtrs to buy Lupin, Sun Pharma: Prabhudas Lilladher

2.02 pm | 24 Jul 2015 |  Source: CNBC-TV18

Pharma Analyst Surajit Pal is not very keen on holding pharma biggies, given the newsflows that are associated with them. Lupin first quarter earnings...

Here are some top trading ideas from Kunj Bansal 

10.16 am | 23 Jul 2015 |  Source: CNBC-TV18

Watch the interview of Kunj Bansal of Centrum Wealth Management with Latha Venkatesh & Sonia Shenoy on CNBC-TV18, in which he shared his readings and ...

Adopt bottoms-up approach; Sun Pharma a good buy: Pros 

4.25 pm | 21 Jul 2015 |  Source: CNBC-TV18

Despite the fall in Sun Pharma on the back of Monday's profit warnings, Parag Thakkar of HDFC Securities and Devang Mehta of Anand Rathi Financial Ser...

Accumulate Sun Pharma with 18-24 months view: Devang Mehta 

3.55 pm | 21 Jul 2015 |  Source: CNBC-TV18

Devang Mehta of Anand Rathi Financial Services recommends accumulating Sun Pharmaceutical Industries with a view of 18-24 months....

Stay away from Sun Pharma, Bharti Airtel, say experts

9.23 am | 21 Jul 2015 |  Source: CNBC-TV18

Dipan Mehta and Prakash Diwan do not think Sun Pharma is currently a great investment....

Ranbaxy integration impact to be controlled from FY17: Sun 

10.08 pm | 20 Jul 2015 |  Source: CNBC-TV18

Supply disruptions from Sun Pharma's Halol facility are also expected to continue for some more time. But the company did not give any timeline for th...

Sun Pharma issues profit warning for FY16

6.27 pm | 20 Jul 2015 |  Source: CNBC-TV18

The consolidated profit in addition to revenue may also be adversely impacted due to certain expenses/ charges arising out of integration and remedial...

Integration costs to continue into FY16: Sun Pharma 

1.19 pm | 01 Jun 2015 |  Source: CNBC-TV18

Sun Pharma CFO Uday Baldota said given the complexity of the merger, it is difficult to give guidance for FY16, adding that the company is undertaking...

Sun will turn Ranbaxy profitable; stock fall brief: Angel 

1.04 pm | 01 Jun 2015 |  Source: CNBC-TV18

Sarabjit Kaur Nangra of Angel Broking is neutral on Cipla as of now because the price has run up ahead of fundamentals....

Ranbaxy effect playing on Sun Pharma's margins: Pros 

7.18 pm | 29 May 2015 |  Source: CNBC-TV18

Sarabjit Kour Nangra, VP- Research, Angel Broking, believes it to be the Ranbaxy effect. However, she says 14.5 percent is very low, because after con...

Sun Pharma Q4 profit seen up 9.7%, sales may rise 16%: Poll 

5.02 pm | 28 May 2015 |  Source: CNBC-TV18

Drug major Sun Pharmaceutical Industries's fourth quarter consolidated profit is likely to increase 9.7 percent year-on-year to Rs 1,659.85 crore, acc...

1 2 3
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.